Table 2.
WBC | 6,500 | /µL | Na | 140 | mEq/dL |
Neut | 71.6 | % | K | 4.8 | mEq/dL |
Eo | 3 | % | TP | 5.5 | g/dL |
Baso | 0.3 | % | Alb | 2.5 | g/dL |
Mono | 9.8 | % | CRP | 5.33 | mg/dL |
Lymp | 12.4 | % | βD-Glucan | <6.0 | pg/mL |
RBC | 3.27×104 | /µL | KL-6 | 1,906 | U/mL |
Hb | 9.5 | g/dL | SP-D | 230 | ng/mL |
Plt | 25.9×104 | /µL | RF | <10 | IU/mL |
AST | 46 | U/L | ANA | <40 | times |
ALT | 18 | U/L | anti-SS-A antibody | (-) | |
ALP | 659 | U/L | PR3-ANCA | <1.0 | IU/mL |
LDH | 189 | U/L | MPO-ANCA | <1.0 | IU/mL |
γ-GTP | 104 | U/L | CMV anitigen* | 0 | cells/2 slides |
BUN | 22 | mg/dL | T-SPOT | (-) | |
Cre | 1.29 | mg/dL |
WBC: white blood cell, Neut: neutrophil, Eo: eosinophil, Baso: basophil, Mono: monocyte, Lymp: lymphocyte, RBC: red blood cell, Hb: hemoglobin, Plt: platelet count, AST: aspartate aminotransferase, ALT: alanine aminotransferase, ALP: alkaline phosphatase, LDH: lactate dehydrogenase, γ-GTP: γ-glutamyl transpeptidase, BUN: blood urea nitrogen, Cre: creatinine, TP: total protein, Alb: albumin, CRP: C-reactive protein, βD-Glucan: beta-d-glucan , KL-6: krebs von den lugen-6, SP-D: surfactant protein D, RF: rheumatoid factor, ANA: antinuclear antibody, anti-SS-A antibody: anti-Sjögren’s-syndrome-related antigen A autoantibodies, PR3-ANCA: proteinase3 antineutrophil cytoplasmic antibody, MPO-ANCA: myeroperoxidase antineutrophil cytoplasmic antibody, CMV antigen: cytomegalovirus antigen, T-SPOT: T-SPOT®-TB
* cytomegalovirus, viral antigen (pp65. C10, C11)